References
- Ge D , FelleyJ, ThompsonAJ et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262) , 399–401 (2009).
- Hughes AR , SpreenWR, MostellerM et al. Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation of clinical utility. Pharmacogenomics J. 8 , 365–374 (2008).
- Warner AW , BienfaitKL, BledsoeM et al. Improving clinical trial sampling for future research – an international approach: outcomes and next steps from the DIA future use sampling workshop 2011. Pharmacogenomics 14(1) , 103–112 (2013).
- Maliepaard M , NofzigerC, PapalucaM et al. Pharmacogenomics in the evaluation of new drugs: a multiregional regulatory perspective. Nat. Rev. Drug Discov. 12(2) , 103–115 (2013).
- Roden DM , AltmanRB, BenowitzNL et al. Pharmacogenomics: challenges and opportunities. Ann. Intern. Med. 145(10) , 749–757 (2006).
- Stone DJ , MolonyC, SuverC, SchadtEE, PotterWZ. ApoE genotyping as a progression-rate biomarker in Phase II disease-modification trials for Alzheimer‘s disease. Pharmacogenomics10(3) , 161–164 (2010).
- Patterson SD , CohenN, KarnoubM et al. Prospective retrospective biomarker analysis for regulatory consideration: a white paper from the Industry Pharmacogenomics Working Group (I-PWG). Pharmacogenomics 12(7) , 939–951 (2011).
- Department of Health and Human Services. Human subjects research protections: enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators. Fed. Regist.76 , 44512–44531 (2011).
- Dal-Ré R , LuqueI, TorresR, LahuertaJ. Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees. Pharmacogenomics9 , 86–89 (2009).
- Gymrek M , McGuireAL, GolanD, HalperinE, ErlichY. Identifying personal genomes by surname inference. Science339(6117) , 321–324 (2013).
▪ Websites
- US FDA. Clinical pharmacogenomics: premarketing evaluation in early phase clinical studies and recommendations for labeling (January 2013) www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM337169.pdf (Accessed 3May2013)
- International Conference on Harmonization E15. Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories (April 2008) www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002880.pdf (Accessed 10January2013)
- Committee for Medicinal Products for Human Use. Reflection Paper on the Use of Genomics in Cardiovascular Clinical Intervention Trials. EMEA (2007). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003865.pdf (Accessed 10January2013)
- Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare, Japan. Guidance: general principles for clinical trials using pharmacogenomics (2008). www.pmda.go.jp/operations/shonin/outline/shinrai/file/tuchi/1_0930007.pdf (Accessed 10January2013)
- US Equal Employment Opportunity Commission. The Genetic Information Nondiscrimination Act of 2008. www.eeoc.gov/laws/types/genetic.cfm (Accessed 26June2013)
- Proposal for a regulation of the European Parliament and of the Council on the protection of individuals with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation) (25 January 2012). http://ec.europa.eu/justice/data-protection/document/review2012/com_2012_11_en.pdf (Accessed 3May2013)
- Goldenberg SJ, Liu, A. China‘s new draft ordinance on human genetic materials and its impact on clinical trials. www.namsa.com/Portals/0/Documents/Whitepapers/NAMSA%20-%20China‘s%20New%20Draft%20Ordinace%20on%20Human%20Genetic%20Materials.pdf (Accessed 26June2013)
- Brazil Ministry of Health. CNS Resolution 441/11 on human biological material storage with the purpose of research (2011). Retrieved from Conselho Nacional de Saúde Brasília Ministério da Saúde website: http://conselho.saude.gov.br/web_comissoes/conep/aquivos/resolucoes/Resolution441_English_contribuicao_pesquisadora.doc (Accessed 26June2013)
- Brazil Ministry of Health. CNS Resolution 340/04: Guidelines for Conduct and Ethical Analysis of Research Projects of the Special Thematic Area of Human Genetics. Retrieved from Conselho Nacional de Saúde Brasília Ministério da Saúde website. http://conselho.saude.gov.br/resolucoes/2004/Reso340.doc (Accessed 10January2013)
- Juan Carlos I. Law 14/2007, of 3 July, on Biomedical Research. Inter-University Chair in Law and the Humane Genome. www.catedraderechoygenomahumano.es/images/novedades/SpanishLawonBiomedicalResearchEnglish.pdf (Accessed 10January2013)
- Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments. www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html?redirect=/clia (Accessed 26June2013)
- GenomeWeb Daily News. UK to Sequence 100K Patient Genomes as NHS Further Adapts Genomic Medicine. www.genomeweb.com/sequencing/uk-sequence-100k-patient-genomes-nhs-further-adapts-genomic-medicine (Accessed 10January2013)
- National Human Genome Research Institute. Electronic Medical Records and Genomics (eMERGE) Network. www.genome.gov/27540473 (Accessed 10January2013)
- International Conference on Harmonization E3. Structure and Content of Clinical Study Reports (November 1995). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_Guideline.pdf (Accessed 10January2013)
- International Conference on Harmonization E3 Q&As R1. Questions & Answers: Structure and Content of Clinical Study Reports (July 2012). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_QAs_R1_Step4.pdf (Accessed 10January2013)